Search papers, labs, and topics across Lattice.
SegGuidedNet, a 3D residual encoder-decoder network, was developed to improve brain tumor sub-region segmentation by introducing a SegAttentionGate module. This module uses a lightweight auxiliary loss to explicitly supervise the decoder, generating spatially discriminative attention maps for necrotic core, peritumoral oedema, and enhancing tumor regions. Evaluated on BraTS2021 and BraTS2023, SegGuidedNet achieved Dice scores of 0.905 and 0.897 respectively, outperforming single-model baselines and approaching ensemble performance with significantly lower inference cost, while also providing inherent spatial interpretability.
Brain tumor segmentation gets a boost in both accuracy and interpretability with SegGuidedNet, a lightweight architecture that rivals ensembles without needing post-hoc explainability.
Accurate segmentation of brain tumour sub-regions from multi-parametric MRI is critical for treatment planning yet remains challenging due to morphological variability, class imbalance, and overlapping appearances of tumour regions across imaging sequences. We propose SegGuidedNet, a three-dimensional residual encoder--decoder network introducing a novel SegAttentionGate module that explicitly supervises the decoder to produce spatially discriminative attention maps for each tumour sub-region necrotic core, peritumoral oedema, and enhancing tumour via a lightweight auxiliary loss, adding less than 0.2% parameter overhead. This sub-region supervision maintains decoder discriminability between visually ambiguous classes while providing free-of-cost spatial interpretability at inference without any post-hoc explanation method. Evaluated independently on BraTS2021 and BraTS2023 GLI across 251 held-out subjects each, SegGuidedNet achieves mean Dice of 0.905 (ET= 0.873, TC=0.906, WT=0.935) and 0.897 (ET=0.859, TC=0.902, WT=0.931) respectively, surpassing ensemble-based nnU-Net and HNF-Netv2 as a single model and approaching Swin UNETR a 10-model ensemble within 2--4 Dice points at a fraction of the inference cost. The consistency of results across two benchmark editions further confirms the generalisability of the proposed approach, offering competitive accuracy with built-in interpretability in a lightweight, clinically practical framework.
